Pilot Haskap Metabolite Timing Project
Launched by MONTANA STATE UNIVERSITY · Apr 14, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Pilot Haskap Metabolite Timing Project is a clinical trial looking at how the foods we eat can impact our health, especially for those at risk of conditions like metabolic syndrome. The trial focuses on the gut microbiome, which is the community of microorganisms in our digestive system. These microorganisms can influence how our bodies absorb healthy compounds found in foods, such as polyphenols, which are beneficial for heart health and reducing inflammation. By understanding this relationship better, the researchers hope to find ways to use diet as a tool for improving health.
To participate in this study, you need to be between 18 and 45 years old with a body mass index (BMI) between 18 and 30. However, certain factors can exclude you, such as having allergies to Haskap berries, recent use of antibiotics, or being pregnant. If you join the trial, you will be required to follow a special diet that avoids foods high in polyphenols for ten days. This trial is currently recruiting participants of all genders, and your involvement can help contribute to important research on how diet can support better health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18-45 years old
- • Body mass index (BMI) between 18-30 kg/m\^2
- Exclusion Criteria:
- • allergy to Haskap berries
- • have taken antibiotics in the last 90 days
- • take dietary supplements
- • have adverse events from blood draws
- • take medication to lower cholesterol, inflammation, lipids
- • smoke cigarettes
- • pregnant and/or lactating
- • have diabetes
- • are unwilling to follow a no-polyphenolic diet for 10 days
About Montana State University
Montana State University (MSU) is a leading research institution committed to advancing health and science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, MSU leverages its robust academic resources and expertise to conduct cutting-edge research that addresses critical health challenges. The university's Clinical Trials Unit is dedicated to ensuring the highest standards of scientific integrity and participant safety, facilitating a diverse range of studies that contribute to the advancement of medical knowledge and the improvement of patient outcomes. Through its commitment to excellence, MSU aims to foster impactful research that benefits both local communities and the broader global population.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bozeman, Montana, United States
Patients applied
Trial Officials
Mary P Miles, PhD
Principal Investigator
Montana State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported